193 related articles for article (PubMed ID: 35730756)
21. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
22. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
Tappenden KA; Edelman J; Joelsson B
J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
[TBL] [Abstract][Full Text] [Related]
23. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
[TBL] [Abstract][Full Text] [Related]
24. Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.
Compher C; Boullata JI; Pickett-Blakely O; Schiavone P; Stoner N; Kinosian BP
JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1183-1190. PubMed ID: 26111832
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Outcomes With Teduglutide From a Single Center.
Puello F; Wall E; Herlitz J; Lozano ES; Semrad C; Micic D
JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):318-322. PubMed ID: 32391948
[TBL] [Abstract][Full Text] [Related]
26. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
Kochar B; Herfarth HH
Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
[TBL] [Abstract][Full Text] [Related]
27. Use of Teduglutide in Children With Intestinal Failure: A Systematic Review.
Gigola F; Cianci MC; Cirocchi R; Ranucci MC; Del Riccio M; Coletta R; Morabito A
Front Nutr; 2022; 9():866518. PubMed ID: 35774551
[TBL] [Abstract][Full Text] [Related]
28. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
[TBL] [Abstract][Full Text] [Related]
29. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
Yazbeck R
Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
[TBL] [Abstract][Full Text] [Related]
30. Necrotizing enterocolitis is associated with earlier achievement of enteral autonomy in children with short bowel syndrome.
Sparks EA; Khan FA; Fisher JG; Fullerton BS; Hall A; Raphael BP; Duggan C; Modi BP; Jaksic T
J Pediatr Surg; 2016 Jan; 51(1):92-5. PubMed ID: 26700691
[TBL] [Abstract][Full Text] [Related]
31. Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
Fifi A; Raphael BP; Terreri B; Uddin S; Kaufman SS
J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):666-671. PubMed ID: 37889619
[TBL] [Abstract][Full Text] [Related]
32. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
Wales PW; Hill S; Robinson I; Raphael BP; Matthews C; Cohran V; Carter B; Venick R; Kocoshis S
J Pediatr Gastroenterol Nutr; 2024 Jun; ():. PubMed ID: 38873891
[TBL] [Abstract][Full Text] [Related]
33. Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption.
George AT; Li BH; Carroll RE
Dig Dis Sci; 2019 Jun; 64(6):1599-1603. PubMed ID: 30730014
[TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
Kocoshis SA; Merritt RJ; Hill S; Protheroe S; Carter BA; Horslen S; Hu S; Kaufman SS; Mercer DF; Pakarinen MP; Venick RS; Wales PW; Grimm AA
JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952
[TBL] [Abstract][Full Text] [Related]
35. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
Seidner DL; Gabe SM; Lee HM; Olivier C; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614
[TBL] [Abstract][Full Text] [Related]
36. Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility.
Raphael BP; Nurko S; Jiang H; Hart K; Kamin DS; Jaksic T; Duggan C
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):590-4. PubMed ID: 21502831
[TBL] [Abstract][Full Text] [Related]
37. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
Micic D; Robinson I; Kidd T; Terreri B; Raphael BP
Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
[TBL] [Abstract][Full Text] [Related]
38. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.
Raghu VK; Binion DG; Smith KJ
Am J Clin Nutr; 2020 Jan; 111(1):141-148. PubMed ID: 31665212
[TBL] [Abstract][Full Text] [Related]
40. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
